- November 06, 2015
With subtypes now defined, future studies could reveal previously unknown contributions of the serotonergic neuronal system to disease, inform the development of biomarkers, or lead to more targeted therapies.
Accelerator supports Harvard faculty in conducting and developing applied life science research.
- September 28, 2015
A molecule isolated from sea sponges and synthesized at Harvard can halt the growth of cancerous cells.
- August 19, 2015
Twelve advanced research projects aimed at developing new therapies and diagnostics receive support in 2015-16 from Harvard’s Blavatnik Biomedical Accelerator.
Five outstanding HBS alumni will work with inventors from Harvard University’s research laboratories to promote the commercialization of innovative life science-oriented technologies with significant market potential.
Page 3 of 5